X-Therma Inc. is solving unmet legacy needs in the storage of biological products using convergent biomimetic nanotechnology. This solution can better enable critical biomanufacture processes, safer transport and long-term biobanking for advanced cell therapies, in vitro fertilization, organ transplants, and other rapidly growing regenerative medicine areas.
Location: United States, California, Richmond
Employees: 11-50
Total raised: $35.4M
Founded date: 2014
Investors 4
| Date | Name | Website |
| 28.12.2021 | Dellin Inv... | dellin.inv... |
| 24.10.2020 | Cavendish ... | cavendishf... |
| - | Lorea AG | lorea-ag.c... |
| 09.06.2021 | VU Venture... | vuventurep... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 15.03.2024 | Series B | $22.4M | - |
| 22.12.2021 | Series A | $13M | - |
Mentions in press and media 8
| Date | Title | Description |
| 20.03.2024 | X-Therma Secures $22.4M for Breakthrough Organ Preservation Technology | X-Therma, a biotech company in San Francisco, has raised $22.4M in Series B funding to advance their regenerative medicine and organ preservation platform. Led by CEO Xiaoxi Wei, the company aims to increase organ availability for transplan... |
| 15.03.2024 | X-Therma Raises $22.4M in Series B Funding | Xiaoxi Wei, Ph.D., Co-founder and CEO of X-Therma, with the TimeSeal® X-Therma, a San Francisco, CA-based biotechnology company developing a platform for regenerative medicine and organ preservation, raised $22.4M in Series B funding. The r... |
| 14.03.2024 | X-Therma Nabs $22.4M Oversubscribed Series B | SAN FRANCISCO, CA, X-Therma has completed an oversubscribed $22.4 million Series B funding round. >> Click here for more funding data on X-Therma >> To export X-Therma funding data to PDF and Excel, click here X-Therma, a... |
| 22.12.2021 | X-Therma Closes Oversubscribed $13M Series A Financing Led by LOREA AG | X-Therma Inc., a biotechnology company developing breakthrough technology for regenerative medicine and organ preservation - has closed an oversubscribed $13M Series A funding round. The financing is led by LOREA AG, an entrepreneur-operate... |
| 22.12.2021 | X-Therma Closes $13M Series A Financing | X-Therma Inc., a Richmond, Calif.-based biotechnology company developing technology for regenerative medicine and organ preservation, closed a $13M Series A funding round. The round was led by Lorea AG, an entrepreneur-operated investment f... |
| 22.12.2021 | X-Therma Closes $13M Series A | RICHMOND, CA, X-Therma, a biotechnology company, has closed an oversubscribed $13M Series A funding round led by LOREA. >> Click here for more funding data on X-Therma >> To export X-Therma funding data to PDF and Excel, cli... |
| - | Behind the billionaire-backed longevity business — and the innovations that could help us live longer | Jeff Bezos, Sam Altman and Peter Thiel can buy whatever they want — even eternal youth? Tech billionaires are pouring massive amounts of their fortune into the bitter battle to be the best Benjamin Button, propelling the market for life-ext... |
| - | X-Therma | “At X-Therma, we're advancing regenerative medicine and organ transplantation with a novel biopreservation solution.” |